Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

CRISPR-Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene and specific sgRNA thereof

A colorectal cancer cell-specific technology, applied in the field of sgRNA, can solve the problem that the molecular mechanism of colorectal cancer has not yet been clarified

Inactive Publication Date: 2018-08-14
OBIO TECH SHANGHAI CORP LTD
View PDF2 Cites 30 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, researchers have done a lot of research on the pathogenesis of colorectal cancer, and have discovered many pathways and mechanisms involved in the progression of colorectal cancer, such as activation of proto-oncogenes, inactivation of tumor suppressor genes (point mutations, rearrangements, deletions) and chromosomal Abnormalities, etc., but the molecular mechanisms involved in the occurrence and progression of colorectal cancer are still unclear, and further research is needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CRISPR-Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene and specific sgRNA thereof
  • CRISPR-Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene and specific sgRNA thereof
  • CRISPR-Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene and specific sgRNA thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] 1. Use CRISPR / Cas9 technology to construct knockout DEAF1 plasmid

[0049] 1.1sgRNA oligonucleotide chain synthesis

[0050] Using the CRISPR online design tool (http: / / crispr.mit.edu / ) according to the scoring system, design a 20bp sgRNA on the second exon of DEAF1, and verify that there is no non-specific gene by BLAST. Add ACCG to the 5'end of the coding strand template, and add AAAC to the 3'end of the non-coding strand template, which are complementary to the sticky ends formed by BsmBI digestion. A pair of CRISPR oligonucleotide strands is designed, see Table 1.

[0051] Table 1 DEAF1 targeting site and sgRNA oligonucleotide sequence

[0052]

[0053] 1.2 Vector construction

[0054] 1.2.1 Use BsmBI to digest 2μg Lenti-CRISPRv2 plasmid (purchased from Addgene), 2h, 37℃, digestion system:

[0055] 2μg (2μl)

Lenti-CRISPRv2

1μl

BsmBI (NEB)

5μl

10X Cutsmart

42μl

ddH 2 O

50μl

total

[0056] 1.2.2 Purify the digested plasmid product using the Jerry Gene Gel Recov...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a CRISPR / Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene and specific sgRNA thereof. The CRISPR / Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene and the specific sgRNA thereof are characterized in that: firstly, sgRNA of a second exon of the specific targeted DEAF1 gene is obtained and the base sequence of the sgRNA is shown as SEQ ID NO.1; secondly, the sgRNA of the DEAF1 gene is constructed into a lentiviral vector system, which contains Cas9 protein; finally, the CRISPR / Cas9 lentivirus containing the sgRNA is infected with human colorectal carcinoma cell HT-29 cell, so that a cell strain of which DEAF1 protein expression level is obviously reduced is obtained. The CRISPR / Cas9 targeted knockout human colorectal carcinoma cell DEAF1 gene disclosed by the invention has the advantages of simple operation steps, good sgRNA target ability and high cutting efficiency for the DEAF1 gene; in addition, the constructed CRISPR / Cas9 lentiviral vector system has the advantage of high knockout efficiency and can specifically knock out the DEAF1 gene to obtain the human colorectal carcinoma cells knocking out the DEAF1 gene, and therebya powerful tool is provided for further studying an action mechanism of DEAF1 in the colorectal carcinoma cells.

Description

Technical field [0001] The invention belongs to the field of genetic engineering, and more specifically relates to CRISPR / Cas9 targeted knockout of the DEAF1 gene of human intestinal cancer cells and its specific sgRNA. Background technique [0002] RBP-J interacting and microtubule-associated protein (DEAF1; C12orf52) is a highly conserved protein with a protein size of 36 kD and no significant homology to any other protein. DEAF1 can interfere with Notch- and RBP-J-mediated transcription. DEAF1 rapidly shuttles between the nucleus and cytoplasm and, most importantly, mediates nuclear export of RBP-J tubulin fibrils. DEAF1, as a novel RBP-J interacting protein, downregulates Notch by interfering with the transcription factor RBP-J. Notch genes encode a class of highly conserved cell surface receptors that regulate the development of cells in a variety of organisms, from sea urchins to humans. Notch signaling affects multiple processes of normal cell morphogenesis, includ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/113C12N15/867C12N5/10C12N15/90
CPCC07K14/4703C12N5/0693C12N7/00C12N15/1135C12N15/86C12N15/907C12N2310/10C12N2510/00C12N2740/15043C12N2800/80C12N2810/10
Inventor 杨蕊菊陆路杨兴林潘讴东
Owner OBIO TECH SHANGHAI CORP LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products